amiodarone
FDA Approved
Description
Amiodarone is a Class III antiarrhythmic agent used for life-threatening ventricular arrhythmias. It is particularly useful in arrhythmogenic ventricular dysplasia and other structural heart diseases with arrhythmias. The drug has multiple mechanisms including potassium channel blockade and beta-blocking effects.
Indications & Therapeutic Use
ventricular tachycardia, ventricular fibrillation, atrial fibrillation, arrhythmogenic ventricular dysplasia
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
amiodarone
| Generic Name | amiodarone |
| Brands | 1 brand available |
| Active Ingredient | amiodarone hydrochloride |
| Drug Class | ventricular tachycardia |
| Manufacturer | Sanofi |
| Dosage Forms | oral tablet 100mg, 200mg, 400mg; IV infusion 50mg/mL |
| Medical Code | C01BD01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00000556 |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes